APC comments on Oregon proposals

This week, APC sent a comment letter to the Oregon Board of Pharmacy regarding proposed rules that will affect human and veterinary compounding. Some of the proposed rules, if adopted as written, do not align with current USP chapters and have the potential to lead to errors and/or patient access issues. The hearing on the proposed rules will be held July 26.

APC and NCPA have sent a joint letter to the Oregon Board of Pharmacy expressing concern about the...

APC this week wrote to the Tennessee Board of Pharmacy to express concern that the board has not...

In a joint letter to FDA Center for Veterinary Medicine Director Steven Solomon, five national...

APC comments on Oregon proposals

Related posts

Couple of quick state updates

APC to Tennessee BOP: Where’s the benefit?

Associations request GFI 256 enforcement delay